Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Bschor

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Der Nervenarzt|March 18, 2017
[Genetic tests for controlling treatment with antidepressants]T Bschor, C Baethge, C Hiemke, et al.
Der Nervenarzt|June 20, 2014
[New facts of long-term prophylaxis for bipolar affective disorder]T Bschor, B Müller-Oerlinghausen, G Stoppe, et al.
Fortschritte Der Neurologie-Psychiatrie|November 24, 1998
[Lithium in the treatment of acute depression]M Adli, T Bschor, B Canata, et al.
Acta Psychiatrica Scandinavica|August 29, 2017
ReplyR Schneibel, G Wilbertz, C Scholz, et al.
Acta Psychiatrica Scandinavica|September 24, 2020
In search of a dose-response relationship in SSRIs-a systematic review, meta-analysis, and network meta-analysisC Braun, A Adams, L Rink, et al.
Pharmacopsychiatry|October 13, 2011
No correlation between lithium serum levels and psychopathological features during the euthymic interval of patients with recurrent affective disorderU Lewitzka, R Scheffczyk, D Ritter, et al.
Pharmacopsychiatry|October 25, 2012
Comparing augmentation with non-antidepressants over sticking to antidepressants after treatment failure in depression: a naturalistic studyS Köhler, T Unger, S Hoffmann, et al.
Pharmacopsychiatry|December 17, 2003
Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanismsT Bschor, U Lewitzka, J Sasse, et al.
Journal of Affective Disorders|April 9, 2001
Subjective response to and tolerability of long-term supraphysiological doses of levothyroxine in refractory mood disordersM Bauer, S Priebe, A Berghöfer, et al.
The American Journal of Psychiatry|August 31, 2000
Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depressionM Bauer, T Bschor, D Kunz, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Der Nervenarzt|March 18, 2017
[Genetic tests for controlling treatment with antidepressants]T Bschor, C Baethge, C Hiemke, et al.
Der Nervenarzt|June 20, 2014
[New facts of long-term prophylaxis for bipolar affective disorder]T Bschor, B Müller-Oerlinghausen, G Stoppe, et al.
Fortschritte Der Neurologie-Psychiatrie|November 24, 1998
[Lithium in the treatment of acute depression]M Adli, T Bschor, B Canata, et al.
Acta Psychiatrica Scandinavica|August 29, 2017
ReplyR Schneibel, G Wilbertz, C Scholz, et al.
Acta Psychiatrica Scandinavica|September 24, 2020
In search of a dose-response relationship in SSRIs-a systematic review, meta-analysis, and network meta-analysisC Braun, A Adams, L Rink, et al.
Pharmacopsychiatry|October 13, 2011
No correlation between lithium serum levels and psychopathological features during the euthymic interval of patients with recurrent affective disorderU Lewitzka, R Scheffczyk, D Ritter, et al.
Pharmacopsychiatry|October 25, 2012
Comparing augmentation with non-antidepressants over sticking to antidepressants after treatment failure in depression: a naturalistic studyS Köhler, T Unger, S Hoffmann, et al.
Pharmacopsychiatry|December 17, 2003
Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanismsT Bschor, U Lewitzka, J Sasse, et al.
Journal of Affective Disorders|April 9, 2001
Subjective response to and tolerability of long-term supraphysiological doses of levothyroxine in refractory mood disordersM Bauer, S Priebe, A Berghöfer, et al.
The American Journal of Psychiatry|August 31, 2000
Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depressionM Bauer, T Bschor, D Kunz, et al.
Pageof 5